Evidence map›Paper›PMID 27510453›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2016

Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease.

Fliss E M Murtagh, Aine Burns, Olivier Moranne, Rachael L Morton, Saraladevi Naicker

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06243068 (Improving Shared Decision-Making and Access to Non-Dialytic Treatment for People With Kidney Disease), which is not on this map. Cited by 54 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 5 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06243068 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Improving Shared Decision-Making and Access to Non-Dialytic Treatment for People With Kidney Disease (The ExPAND Trial)

TypeinterventionalSponsorGeorge Washington UniversityRan2024 to 2028Enrolled3,000ConditionsChronic Kidney DiseaseArmsEducate and Engage, Educate and Engage Plus Kidney Supportive Care Program
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 5 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Care of Adults with Advanced Chronic Kidney Disease.Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Fliss E M MurtaghDepartment of Palliative Care, Policy and Rehabilitation, Cicely Saunders Institute, King's College London, London, United Kingdom.
Aine BurnsDepartment of Nephrology, Royal Free Hospital National Health Service Foundation Trust, London, United Kingdom.
Olivier MoranneInstitut Universitaire de Recherche Clinique, EA2415, Epidémiologie, Biostatistiques et santé publique, Faculté de Médecine, Université de Montpellier, Montpellier, France.
Rachael L MortonNational Health and Medical Research Centre Clinical Trials Centre, University of Sydney, Sydney, Australia; and.
Saraladevi NaickerDepartment of Internal Medicine, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.
King's College London · GBNational Health Service · GBUniversité de Montpellier · FRUniversity of Sydney · AUUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comprehensive conservative (nondialytic) kidney care is widely recognized and delivered but until recently, has not been clearly defined. We provide a clear definition of comprehensive conservative care. This includes interventions to delay progression of kidney disease and minimize complications as well as detailed communication, shared decision making, advance care planning, and psychologic and family support. It does not include dialysis. Limited epidemiologic evidence from Australia and Canada indicates that, for every new person diagnosed with ESRD who receives dialysis or transplant, there is one new person who is managed conservatively (either actively or not). For older patients (those >75 or 80 years old) who have higher levels of comorbidity (such as diabetes and heart disease) and poorer functional status, the survival advantage of dialysis may be limited, and comprehensive conservative management may be considered; however, robust comparative evidence remains limited. Considerations of symptoms, quality of life, and hospital-free days are as or sometimes more important for patients and families than survival. There is some evidence that communication about possible conservative management options is generally insufficient, even where comprehensive conservative care pathways are already established. Symptom control and the cost-effectiveness of interventions are addressed in the companion papers within this Moving Points in Nephrology series. There is almost no evidence about which models of care and which interventions might be most beneficial in this population; future research on these areas is much needed. Meanwhile, consistency in definition of comprehensive conservative care and basing interventions on existing evidence about survival, symptoms, quality of life, and experience will maximize patient-centered and holistic care.

Indexed as

Conservative TreatmentQuality of LifeHospitalizationHumansKidney Failure, ChronicSurvival RateSymptom AssessmentAdvance Care PlanningAustraliaCanadaChronicchronic kidney diseaseComorbidityconservative carediabetes mellitusHeart DiseasesHumansKidney Failurepalliative carepatient-centered carePrevalencequality of liferenal dialysisRenal Insufficiencysupportive care

Identifiers

PMID27510453
PMCPMC5053791
OpenAlexW2462106710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.